The aim of this project was to update and further develop the Moore (2005) Australian drug budget. As in the earlier Moore project, our study examined both federal and state and territory government spending in response to illicit drugs but only included proactive spending. This is the amount directly spent by government on illicit drug policy. The expenditures weare broken down into the areas of prevention, treatment, harm reduction, and law enforcement.
Dr Ross McLeod (Consultant - eSYS Development)
- update the expenditure framework developed by Moore (2005) for classifying and measuring government drug spending in Australia;
- develop a framework for identifying which drug-specific interventions are included in the cost analysis, along with the assumptions underpinning calculations being presented; and
- calculate annual drug expenditure for the year 2009/10 by the federal and state/territory governments in Australia.
- Identify all types of interventions and areas of spending. Define those that are ‘direct’ spending.
- Categorise interventions into Prevention, Treatment, Enforcement, Harm Reduction
- Using top-down accounting methods, access and review multiple data sources to ascertain spending estimates and calculate spending, applying adjustments as required.
|Policy domain||$ million||Percentage|
DPMP Monograph 24: Government drug policy expenditure in Australia - 2009/10 (published August 2013).
The data from this study provide information on the funding mix in illicit drug policy. Illicit drugs cause significant health, social and economic burdens on Australian society. Australian governments’ investment in this area represents a tiny component of all government spending (0.8%). The extent to which the policy mix of spending across domains identified here represents efficient spending cannot be ascertained from this study; new research examining the relative cost-efficiencies for each of the four policy domains is now required.